NCT05088603

Brief Summary

The purpose of this research study is to evaluate participants' experience and satisfaction during the awake deep brain stimulation (DBS) procedure. Normally, the neurologist will ask the participant questions and also ask the participant to perform tasks during surgery. During this time, the neurologist will be talking to the participant and the participant will be responding by answering questions or participating with the tasks. For some study participants, there will be one small change made to the typical way the neurologist conducts this evaluation. The study staff will then ask the study participants about their experience with the neurologist's evaluation. The subject will not be told what part of the evaluation is changed for the study, until after they have responded to the questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 22, 2021

Completed
25 days until next milestone

Study Start

First participant enrolled

November 16, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
12 months until next milestone

Results Posted

Study results publicly available

July 18, 2024

Completed
Last Updated

July 29, 2024

Status Verified

September 1, 2023

Enrollment Period

1.7 years

First QC Date

October 13, 2021

Results QC Date

June 25, 2024

Last Update Submit

July 19, 2024

Conditions

Keywords

clear maskneurological conditiondeep brain stimulationbrain surgeryneurology

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With a Positive Response Score of 4 to Question 1 on the Clinician & Group Survey-Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Questionnaire

    Questionnaire measures the subject's satisfaction and experience with his or her physician and/or physician practice. Question #1 of the CG-CAHPS is "Did this provider explain things in a way that was easy to understand?" with 1 meaning "not at all" and 4 meaning "completely". Responses 1-3 were considered negative and response 4 considered positive. Outcome is count of positive responses.

    Day 1 Post Surgery

Secondary Outcomes (10)

  • Number of Participants With a Positive Response Score of 4 to Question 2 on the Clinician & Group Survey-Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Questionnaire

    Day 1 Post Surgery

  • Number of Participants With a Positive Response Score of 4 to Question 3 on the Clinician & Group Survey-Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Questionnaire

    Day 1 Post Surgery

  • Number of Participants With a Positive Response Score of 4 to Question 4 on the Clinician & Group Survey-Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Questionnaire

    Day 1 Post Surgery

  • Number of Participants With a Positive Response Score of 4 to Question 5 on the Clinician & Group Survey-Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Questionnaire

    Day 1 Post Surgery

  • Number of Participants With a Positive Response Score of 4 to Question 6 on the Clinician & Group Survey-Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Questionnaire

    Day 1 Post Surgery

  • +5 more secondary outcomes

Study Arms (2)

Clear Mask

EXPERIMENTAL

Subjects randomized to this group will have a neurologist who wears a clear mask during their procedure and during their interaction with the subject.

Device: Clear Mask

Standard Mask

NO INTERVENTION

Subjects randomized to this group will have a neurologist who wears a standard mask during their procedure and during their interaction with the subject.

Interventions

The clear mask has a 4.75 x 1.35 inch clear window that allows for clear visibility of the mouth.

Clear Mask

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients electing to undergo deep brain stimulator placement
  • Patient in whom general anesthesia is not planned for stimulator target localization

You may not qualify if:

  • Patients who do not give consent
  • Patients who do not undergo DBS placement
  • Patients who are blind or have a severe visual impairment
  • Non-English speaking patients (i.e., patients for whom an interpreter would be needed to conduct the intra-operative assessment)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

CommunicationPatient Satisfaction

Condition Hierarchy (Ancestors)

BehaviorTreatment Adherence and ComplianceHealth Behavior

Results Point of Contact

Title
Dr. Kyle Fargen
Organization
Atrium Health Wake Forest Baptist Health Department of Neurosurgery

Study Officials

  • Wesley Hsu, MD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The neurologist will wear the mask type assigned by randomization for the duration of involvement in the surgery. At the conclusion of the neurologist's interaction with the participant, the participant will be asked a series of questions to evaluate the communication experience. This step will be performed by another member of the study team (not the participating neurologist) who will read from the questionnaire and record the participant's responses. During questioning, the neurologist will step out of the operating room to reduce potential bias from the participants answering subjective questions in front of the neurologist.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 13, 2021

First Posted

October 22, 2021

Study Start

November 16, 2021

Primary Completion

July 31, 2023

Study Completion

July 31, 2023

Last Updated

July 29, 2024

Results First Posted

July 18, 2024

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations